These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8060520)

  • 21. Action of the 5-HT2A antagonist amperozide on alcohol-induced poikilothermia in rats.
    Myers RD; Lankford M
    Pharmacol Biochem Behav; 1998 Jan; 59(1):91-5. PubMed ID: 9443541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of DOV 102,677 on the volitional consumption of ethanol by Myers' high ethanol-preferring rat.
    McMillen BA; Shank JE; Jordan KB; Williams HL; Basile AS
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1866-71. PubMed ID: 17908267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats.
    Panocka I; Ciccocioppo R; Pompei P; Massi M
    Pharmacol Biochem Behav; 1993 Dec; 46(4):853-6. PubMed ID: 7508629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
    Uvnäs-Moberg K; Alster P; Svensson TH
    Psychopharmacology (Berl); 1992; 109(4):473-6. PubMed ID: 1365865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
    Klint T; Dahlgren IL; Larsson K
    Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.
    Pehek EA; Meltzer HY; Yamamoto BK
    Eur J Pharmacol; 1993 Aug; 240(1):107-9. PubMed ID: 8405119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological impact of trazodone on the dopamine and norepinephrine systems in the rat brain.
    Ghanbari R; El Mansari M; Blier P
    Eur Neuropsychopharmacol; 2012 Jul; 22(7):518-26. PubMed ID: 22154666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist.
    Panocka I; Pompei P; Massi M
    Brain Res Bull; 1993; 31(5):595-9. PubMed ID: 7684315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of brain dopa-decarboxylase by RO 4-4602 infused ICV blocks alcohol drinking induced in rats by cyanamide.
    Miñano FJ; Myers RD
    Psychopharmacology (Berl); 1989; 98(2):176-82. PubMed ID: 2502790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central action of an inhibitor of brain dopa-decarboxylase, NSD-1015, on cyanamide-induced alcohol drinking in rats.
    Miñano FJ; McMillen BA; Myers RD
    Pharmacol Biochem Behav; 1990 Feb; 35(2):465-8. PubMed ID: 2320657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amperozide influences feeding independently of 5-HT2A receptor antagonism.
    Price IV; Gorzalka BB; White SJ; Arkinstall KH
    Neuropsychobiology; 1998; 37(3):155-9. PubMed ID: 9597673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age dependent development of ethanol drinking in rats after inhibition of aldehyde dehydrogenase.
    Barwick VS; Myers RD
    Alcohol; 1992; 9(6):501-7. PubMed ID: 1472305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.
    Axelsson R; Nilsson A; Christensson E; Björk A
    Psychopharmacology (Berl); 1991; 104(3):287-92. PubMed ID: 1924636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT1A agonists: alcohol drinking in rats and squirrel monkeys.
    McKenzie-Quirk SD; Miczek KA
    Psychopharmacology (Berl); 2003 May; 167(2):145-52. PubMed ID: 12658527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.
    Schreiber R; Opitz K; Glaser T; De Vry J
    Psychopharmacology (Berl); 1993; 112(1):100-10. PubMed ID: 7870997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.